Pilot evaluation of anti-1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinoma.
Savir-Baruch B, Schuster DM, Jarkas N, Master VA, Nieh PT, Halkar RK, Nye JA, Lewis MM, Crowe RJ, Voll RJ, Camp VM, Bellamy LM, Roberts DL, Goodman MM.
Savir-Baruch B, et al. Among authors: schuster dm.
Mol Imaging Biol. 2011 Dec;13(6):1272-7. doi: 10.1007/s11307-010-0445-3.
Mol Imaging Biol. 2011.
PMID: 20976627
Free PMC article.